Glucocorticoid does not improve the renal prognosis of patients with diabetic nephropathy combined with acute tubulointerstitial nephritis: a retrospective analysis-Reference-Cited by-同舟云学术

Glucocorticoid does not improve the renal prognosis of patients with diabetic nephropathy combined with acute tubulointerstitial nephritis: a retrospective analysis

Published:2024-07-18 Issue:2 Volume:46 Page:
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Tian Jingwei¹²,Shi Jingxuan³⁴,Jiao Yuanyuan⁵,Liu Xinze³⁶,An Jiaqi³⁷,Yang Yue³,Zou Guming³,Zhuo Li³

Affiliation:

1. Department of Nephrology, Beijing No.6 Hospital, Beijing, China

2. Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China

3. Department of Nephrology, China-Japan Friendship Hospital, Beijing, China

4. Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China

5. Department of Nephrology, Fuwai Hospital, Chinese Academy of Medical Science, Beijing, China

6. Beijing University of Chinese Medicine China-Japan Friendship Clinic Medical College, Beijing, China

7. China-Japan Friendship Clinic Medical College, Peking University, Beijing, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2024.2379002

Reference35 articles.

1. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes

2. Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”

3. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

4. Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation

5. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes